These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28825411)

  • 21. Cell biology, molecular embryology, Lamarckian and Darwinian selection as evolvability.
    Hoenigsberg H
    Genet Mol Res; 2003 Mar; 2(1):7-28. PubMed ID: 12917798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms.
    Koonin EV; Wolf YI
    Biol Direct; 2016 Feb; 11(1):9. PubMed ID: 26912144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General formulation of Luria-Delbrück distribution of the number of mutants.
    Houchmandzadeh B
    Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Jul; 92(1):012719. PubMed ID: 26274214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuation test for two-stage mutations: application to gene amplification.
    Kimmel M; Axelrod DE
    Mutat Res; 1994 Apr; 306(1):45-60. PubMed ID: 7512202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of Escherichia coli CRISPR-Cas system on lytic bacteriophages with different lifestyles and development strategies.
    Strotskaya A; Savitskaya E; Metlitskaya A; Morozova N; Datsenko KA; Semenova E; Severinov K
    Nucleic Acids Res; 2017 Feb; 45(4):1946-1957. PubMed ID: 28130424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A robust estimator of mutation rates.
    Wu X; Strome ED; Meng Q; Hastings PJ; Plon SE; Kimmel M
    Mutat Res; 2009 Feb; 661(1-2):101-9. PubMed ID: 19100753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluctuation analysis on mutation models with birth-date dependence.
    Mazoyer A
    Math Biosci; 2018 Sep; 303():83-100. PubMed ID: 29932952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outline of a unified Darwinian evolutionary theory for physical and biological systems.
    Baladrón C; Khrennikov A
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt A):80-87. PubMed ID: 28526354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mean field mutation dynamics and the continuous Luria-Delbrück distribution.
    Kashdan E; Pareschi L
    Math Biosci; 2012 Dec; 240(2):223-30. PubMed ID: 22929625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Lamarckian evolution relevant to medicine?
    Handel AE; Ramagopalan SV
    BMC Med Genet; 2010 May; 11():73. PubMed ID: 20465829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging Tumorigenesis and Therapy Resistance With a Non-Darwinian and Non-Lamarckian Mechanism of Adaptive Evolution.
    Catania F; Ujvari B; Roche B; Capp JP; Thomas F
    Front Oncol; 2021; 11():732081. PubMed ID: 34568068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luria-Delbrück fluctuation experiments: design and analysis.
    Jones ME; Thomas SM; Rogers A
    Genetics; 1994 Mar; 136(3):1209-16. PubMed ID: 8005425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved inference of mutation rates: II. Generalization of the Luria-Delbrück distribution for realistic cell-cycle time distributions.
    Oprea M; Kepler TB
    Theor Popul Biol; 2001 Feb; 59(1):49-59. PubMed ID: 11243928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. We Should Not Use the Term "Lamarckian" as It Is Often Used in Opposition to "Darwinian".
    Speijer D
    Bioessays; 2019 Sep; 41(9):e1900092. PubMed ID: 31309601
    [No Abstract]   [Full Text] [Related]  

  • 35. A modified Luria-Delbrück fluctuation assay for estimating and comparing mutation rates.
    Crane GJ; Thomas SM; Jones ME
    Mutat Res; 1996 Jul; 354(2):171-82. PubMed ID: 8764946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved inference of mutation rates: I. An integral representation for the Luria-Delbrück distribution.
    Kepler TB; Oprea M
    Theor Popul Biol; 2001 Feb; 59(1):41-8. PubMed ID: 11243927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic delay in the evolution of bacterial antibiotic resistance: Mechanistic models and their implications.
    Carballo-Pacheco M; Nicholson MD; Lilja EE; Allen RJ; Waclaw B
    PLoS Comput Biol; 2020 May; 16(5):e1007930. PubMed ID: 32469859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing mutation rates under the Luria-Delbrück protocol.
    Zheng Q
    Genetica; 2016 Jun; 144(3):351-9. PubMed ID: 27188462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A generalized Luria-Delbrück model.
    Dewanji A; Luebeck EG; Moolgavkar SH
    Math Biosci; 2005 Oct; 197(2):140-52. PubMed ID: 16137718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The number of neutral mutants in an expanding Luria-Delbrück population is approximately Fréchet.
    Frank SA
    F1000Res; 2022; 11():1254. PubMed ID: 36845325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.